Recent technological advancements have significantly transformed diabetes management, notably through the development of automated insulin delivery (AID) systems designed to reduce disease burden and enhance glycemic control for individuals with type 1 diabetes (3). The gene discussed is INS; the disease is type 1 diabetes mellitus.